These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32749403)

  • 21. Hydrogen-exchange mass spectrometry reveals activation-induced changes in the conformational mobility of p38alpha MAP kinase.
    Sours KM; Kwok SC; Rachidi T; Lee T; Ring A; Hoofnagle AN; Resing KA; Ahn NG
    J Mol Biol; 2008 Jun; 379(5):1075-93. PubMed ID: 18501927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current status and future prospects of p38α/MAPK14 kinase and its inhibitors.
    Madkour MM; Anbar HS; El-Gamal MI
    Eur J Med Chem; 2021 Mar; 213():113216. PubMed ID: 33524689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-amino-pyrazoles as potent and selective p38α inhibitors.
    Das J; Moquin RV; Dyckman AJ; Li T; Pitt S; Zhang R; Shen DR; McIntyre KW; Gillooly K; Doweyko AM; Newitt JA; Sack JS; Zhang H; Kiefer SE; Kish K; McKinnon M; Barrish JC; Dodd JH; Schieven GL; Leftheris K
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6886-9. PubMed ID: 21035336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescence polarization binding assay to develop inhibitors of inactive p38alpha mitogen-activated protein kinase.
    Munoz L; Selig R; Yeung YT; Peifer C; Hauser D; Laufer S
    Anal Biochem; 2010 Jun; 401(1):125-33. PubMed ID: 20175985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamics in the p38alpha MAP kinase-SB203580 complex observed by liquid-state NMR spectroscopy.
    Honndorf VS; Coudevylle N; Laufer S; Becker S; Griesinger C
    Angew Chem Int Ed Engl; 2008; 47(19):3548-51. PubMed ID: 18389508
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthetic phosphorylation of p38α recapitulates protein kinase activity.
    Chooi KP; Galan SR; Raj R; McCullagh J; Mohammed S; Jones LH; Davis BG
    J Am Chem Soc; 2014 Feb; 136(5):1698-701. PubMed ID: 24393126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular modeling of p38α mitogen-activated protein kinase inhibitors through 3D-QSAR and molecular dynamics simulations.
    Chang HW; Chung FS; Yang CN
    J Chem Inf Model; 2013 Jul; 53(7):1775-86. PubMed ID: 23808966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the hinge glycine flip and the activation loop: novel approach to potent p38α inhibitors.
    Martz KE; Dorn A; Baur B; Schattel V; Goettert MI; Mayer-Wrangowski SC; Rauh D; Laufer SA
    J Med Chem; 2012 Sep; 55(17):7862-74. PubMed ID: 22897496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contributions of water transfer energy to protein-ligand association and dissociation barriers: Watermap analysis of a series of p38α MAP kinase inhibitors.
    Pearlstein RA; Sherman W; Abel R
    Proteins; 2013 Sep; 81(9):1509-26. PubMed ID: 23468227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NMR spectroscopic investigations of the activated p38α mitogen-activated protein kinase.
    Nielsen G; Schwalbe H
    Chembiochem; 2011 Nov; 12(17):2599-607. PubMed ID: 22012687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological testing of N-aminoimidazole-based p38alpha MAP kinase inhibitors.
    Bracht C; Hauser DR; Schattel V; Albrecht W; Laufer SA
    ChemMedChem; 2010 Jul; 5(7):1134-42. PubMed ID: 20473979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p38alpha mitogen-activated protein kinase inhibitors: optimization of a series of biphenylamides to give a molecule suitable for clinical progression.
    Aston NM; Bamborough P; Buckton JB; Edwards CD; Holmes DS; Jones KL; Patel VK; Smee PA; Somers DO; Vitulli G; Walker AL
    J Med Chem; 2009 Oct; 52(20):6257-69. PubMed ID: 19772287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Comprehensive Structural Overview of p38α Mitogen-Activated Protein Kinase in Complex with ATP-Site and Non-ATP-Site Binders.
    Astolfi A; Manfroni G; Cecchetti V; Barreca ML
    ChemMedChem; 2018 Jan; 13(1):7-14. PubMed ID: 29210532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural basis of p38α regulation by hematopoietic tyrosine phosphatase.
    Francis DM; Różycki B; Koveal D; Hummer G; Page R; Peti W
    Nat Chem Biol; 2011 Nov; 7(12):916-24. PubMed ID: 22057126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The discovery of novel protein kinase inhibitors by using fragment-based high-throughput x-ray crystallography.
    Gill A; Cleasby A; Jhoti H
    Chembiochem; 2005 Mar; 6(3):506-12. PubMed ID: 15696598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two classes of p38alpha MAP kinase inhibitors having a common diphenylether core but exhibiting divergent binding modes.
    Michelotti EL; Moffett KK; Nguyen D; Kelly MJ; Shetty R; Chai X; Northrop K; Namboodiri V; Campbell B; Flynn GA; Fujimoto T; Hollinger FP; Bukhtiyarova M; Springman EB; Karpusas M
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5274-9. PubMed ID: 16169718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-based 3D-QSAR models and dynamics analysis of novel N-benzyl pyridinone as p38α MAP kinase inhibitors for anticytokine activity.
    Ul-Haq Z; Khan W; Zia SR; Iqbal S
    J Mol Graph Model; 2012 Jun; 36():48-61. PubMed ID: 22534481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3,4-Diaryl-isoxazoles and -imidazoles as potent dual inhibitors of p38alpha mitogen activated protein kinase and casein kinase 1delta.
    Peifer C; Abadleh M; Bischof J; Hauser D; Schattel V; Hirner H; Knippschild U; Laufer S
    J Med Chem; 2009 Dec; 52(23):7618-30. PubMed ID: 19591487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and evaluation of 7-alkyl-1,5-bis-aryl-pyrazolopyridinones as highly potent, selective, and orally efficacious inhibitors of p38alpha mitogen-activated protein kinase.
    Pettus LH; Wurz RP; Xu S; Herberich B; Henkle B; Liu Q; McBride HJ; Mu S; Plant MH; Saris CJ; Sherman L; Wong LM; Chmait S; Lee MR; Mohr C; Hsieh F; Tasker AS
    J Med Chem; 2010 Apr; 53(7):2973-85. PubMed ID: 20218619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enzyme fragment complementation binding assay for p38alpha mitogen-activated protein kinase to study the binding kinetics of enzyme inhibitors.
    Zaman GJ; van der Lee MM; Kok JJ; Nelissen RL; Loomans EE
    Assay Drug Dev Technol; 2006 Aug; 4(4):411-20. PubMed ID: 16945014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.